UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Flashback Foreword: Cisplatin/Pemetrexed in Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-05, Vol.41 (14), p.2455-2456

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Encorafenib and Binimetinib: A New Treatment Option for BRAFV600E-Mutant Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-07, Vol.41 (21), p.3679-3681

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-05, Vol.41 (15), p.2671-2672

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Flashback Foreword: Pemetrexed and Cisplatin in Mesothelioma

Journal of clinical oncology, 2023-04, Vol.41 (12), p.2123-2124

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-06, Vol.41 (16), p.2867-2868

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-02, Vol.388 (6), p.489-498

2023

Volltextzugriff (PDF)

Encorafenib and Binimetinib: A New Treatment Option for BRAF V600E -Mutant Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-07, Vol.41 (21), p.3679-3681

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Flashback Foreword: Bevacizumab + Carboplatin/Paclitaxel in NSCLC

Journal of clinical oncology, 2023-05, Vol.41 (13), p.2303-2304

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial

Journal of clinical oncology, 2023-02, Vol.41 (6), p.1159-1160

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

KRAS Mutation: Should We Test for It, and Does It Matter?

Journal of clinical oncology, 2013-03, Vol.31 (8), p.1112-1121

2013

Volltextzugriff (PDF)

Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer

Drugs (New York, N.Y.), 2022-06, Vol.82 (8), p.855-863

2022

Volltextzugriff (PDF)

Current Treatments for Surgically Resectable, Limited‐Stage, and Extensive‐Stage Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2017-12, Vol.22 (12), p.1510-1517

Stinchcombe, Thomas E.

2017

Volltextzugriff (PDF)

Current management of RET rearranged non-small cell lung cancer

Therapeutic Advances in Medical Oncology, 2020, Vol.12, p.1758835920928634-1758835920928634

Stinchcombe, Thomas E

2020

Volltextzugriff (PDF)

Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1387-1394

2017

Volltextzugriff (PDF)

IMpower 131: The Exception to the Rule

Journal of thoracic oncology, 2020-08, Vol.15 (8), p.1258-1260

Stinchcombe, Thomas E.

2020

Volltextzugriff (PDF)

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel

Nanomedicine (London, England), 2007-08, Vol.2 (4), p.415-423

Stinchcombe, Thomas E

2007

Volltextzugriff (PDF)

Narrative review: blood and tumor biomarker testing in non-small cell lung cancer without an oncogenic driver

Translational lung cancer research, 2023-01, Vol.12 (1), p.158-167

Stinchcombe, Thomas E.

2023

Volltextzugriff (PDF)

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2117-2124

2017

Volltextzugriff (PDF)

Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial

Translational lung cancer research, 2023-07, Vol.12 (7), p.1655-1657

Stinchcombe, Thomas E.

2023

Volltextzugriff (PDF)

Personalized Medicine in Non–Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4769-4777

2010

Volltextzugriff (PDF)

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

Clinical cancer research, 2019-01, Vol.25 (1), p.64-72

2019

Volltextzugriff (PDF)

Thoracic Oncology: Current Standard Therapy and Future Developments

Journal of clinical oncology, 2022-02, Vol.40 (6), p.527-529

2022

Volltextzugriff (PDF)

Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

Chest, 2013-05, Vol.143 (5 Suppl), p.e341S-e368S

2013

Volltextzugriff (PDF)

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

Clinical cancer research, 2019-10, Vol.25 (19), p.5832-5842

2019

Volltextzugriff (PDF)

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

Journal of clinical oncology, 2023-05, Vol.41 (13), p.2394-2402

2023

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Englisch
(261)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(176)
Oncology
(157)
Humans
(149)
Lung Neoplasms - Drug Therapy
(79)
Male
(71)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(69)
Female
(69)
Aged
(60)
Lung Neoplasms - Pathology
(59)
Neoplasm Staging
(53)
Carcinoma, Non-Small-Cell Lung - Pathology
(52)
Middle Aged
(52)
Respiratory System
(49)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(47)
Adult
(38)
Lung Cancer
(38)
Aged, 80 And Over
(33)
Chemotherapy
(31)
Lung Neoplasms - Mortality
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Flashback Foreword: Cisplatin/Pemetrexed in Non-Small-Cell Lung Cancer

Encorafenib and Binimetinib: A New Treatment Option for BRAFV600E-Mutant Non-Small-Cell Lung Cancer

Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung Cancer

Flashback Foreword: Pemetrexed and Cisplatin in Mesothelioma

Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

Encorafenib and Binimetinib: A New Treatment Option for BRAF V600E -Mutant Non-Small-Cell Lung Cancer

Flashback Foreword: Bevacizumab + Carboplatin/Paclitaxel in NSCLC

Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial

KRAS Mutation: Should We Test for It, and Does It Matter?

Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer

Current Treatments for Surgically Resectable, Limited‐Stage, and Extensive‐Stage Small Cell Lung Cancer

Current management of RET rearranged non-small cell lung cancer

Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy

IMpower 131: The Exception to the Rule

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel

Narrative review: blood and tumor biomarker testing in non-small cell lung cancer without an oncogenic driver

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial

Personalized Medicine in Non–Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

Thoracic Oncology: Current Standard Therapy and Future Developments

Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

Suchergebnisse filtern